Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Tyler Technologies Reports Earnings for First Quarter 2019

Published

on

Reading Time: 11 minutes

Subscription revenues grew 37% as bookings rose 17%

PLANO, Texas–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24TYL&src=ctag” target=”_blank”gt;$TYLlt;/agt; lt;a href=”https://twitter.com/hashtag/earnings?src=hash” target=”_blank”gt;#earningslt;/agt;–Tyler
Technologies, Inc.
(NYSE: TYL) today announced financial results for
the first quarter ended March 31, 2019.

First Quarter 2019 Financial Highlights:

  • Total revenues were $247.1 million, up 11.7% from $221.2 million for
    the first quarter of 2018. Organic revenue growth was 5.5%. Non-GAAP
    total revenues were $248.8 million, up 12.4% from $221.4 million for
    the first quarter of 2018. Non-GAAP organic revenue growth was 5.4%.
  • Recurring revenues from maintenance and subscriptions were $167.4
    million, an increase of 17.1% compared to the first quarter of 2018,
    and comprised 67.8% of first quarter 2019 revenue.
  • Operating income was $34.5 million, down 11.2% from $38.8 million for
    the first quarter of 2018. Non-GAAP operating income was $63.0
    million, up 7.4% from $58.6 million for the first quarter of 2018.
  • Net income was $27.3 million, or $0.69 per diluted share, down 27.7%
    compared to $37.8 million, or $0.95 per diluted share, for the first
    quarter of 2018. Non-GAAP net income was $48.3 million, or $1.22 per
    diluted share, up 7.3% compared to $45.0 million, or $1.13 per diluted
    share, for the first quarter of 2018.
  • Cash flows from operations were $24.0 million, down 46.3% compared to
    $44.6 million for the first quarter of 2018.
  • Adjusted EBITDA was $69.5 million, up 8.0% compared to $64.4 million
    for the first quarter of 2018.
  • Tyler repurchased 71,793 shares of its common stock during the quarter
    at an average price of $199.03.
  • Software subscription arrangements comprised approximately 54% of the
    total new software contract value in the first quarter.
  • Software subscription bookings in the first quarter added $11.4
    million in annual recurring revenue.
  • Total backlog was $1.26 billion, up 4.9% from $1.20 billion at
    March 31, 2018. Software-related backlog (excluding appraisal
    services) was $1.22 billion, up 4.8% from $1.16 billion at March 31,
    2018.
  • During the quarter, Tyler completed the acquisitions of MyCivic and
    MicroPact, Inc., for a total of $199.1 million in cash, net of cash
    acquired.
  • Effective January 1, 2019, Tyler adopted the requirements of ASU No.
    2016-02, Leases (Topic 842), utilizing the modified retrospective
    method of transition.

“Our first quarter results provided a solid start to 2019 in line with
our expectations,” said Lynn Moore Jr., Tyler’s president and chief
executive officer. “Total non-GAAP revenues grew more than 12%, once
again fueled by strong subscription revenue growth, which grew 38.5% on
a non-GAAP basis. Subscription agreements made up the majority of our
new software contracts in the quarter, and our four largest software
contracts signed in the quarter were all subscription arrangements,
which put pressure on short-term top-line growth but is a long-term
positive trend for Tyler. Our non-GAAP gross margin rose 130 basis
points while our non-GAAP operating margin fell 120 basis points.
Research and development expense rose 45%, reflecting a continued high
level of investment in products across the company, including heightened
investments in recent acquisitions.

“This was a good quarter for bookings, which increased 17% over the
first quarter of 2018, and contributed to our backlog growth of 5%.
Contract signings were particularly strong for our public safety, ERP,
and appraisal and tax products, and our new business pipeline remains
active.

“We are pleased with the continued integration of our 2018 acquisitions
into Tyler and their results were in line with our expectations. We’re
also excited about the February acquisitions of MyCivic and MicroPact.
MyCivic will elevate Tyler’s current citizen-facing applications by
enabling clients to provide a single app for citizens to interact with
their local government in multiple ways. MicroPact is the second largest
acquisition in the company’s history and augments our product solutions,
positions us in new practice areas such as health and human services,
and presents opportunities to expand our business across new and
complementary markets, including the federal market,” added Moore.

Guidance for 2019

As of May 1, 2019, Tyler Technologies is providing the following
guidance for the full year 2019:

  • GAAP total revenues are expected to be in the range of $1.08 billion
    to $1.10 billion. Non-GAAP total revenues are expected to be in the
    range of $1.09 billion to $1.11 billion.
  • GAAP diluted earnings per share are expected to be in the range of
    $3.45 to $3.60 and may vary significantly due to the impact of stock
    option exercises on the GAAP effective tax rate, as well as final
    valuation of acquired intangibles.
  • Non-GAAP diluted earnings per share are expected to be in the range of
    $5.20 to $5.35.
  • Pretax non-cash, share-based compensation expense is expected to be
    approximately $62 million.
  • Research and development expense is expected to be in the range of $82
    million to $84 million.
  • Fully diluted shares for the year are expected to be in the range of
    40.0 million to 41.0 million shares.
  • GAAP earnings per share assumes an estimated annual effective tax rate
    of approximately 10% after discrete tax items and includes
    approximately $27 million of discrete tax benefits related to
    share-based compensation.
  • The non-GAAP annual effective tax rate is expected to be 24%.
  • Capital expenditures are expected to be in the range of $48 million to
    $50 million, including approximately $22 million related to real
    estate and approximately $6 million of capitalized software
    development. Total depreciation and amortization expense is expected
    to be approximately $77 million, including approximately $51 million
    from amortization of acquisition intangibles.

GAAP to non-GAAP guidance reconciliation

Non-GAAP total revenues is derived from adding back the estimated full
year impact of write-downs of acquisition-related deferred revenue and
amortization of acquired leases of approximately $10 million. Non-GAAP
diluted earnings per share excludes the estimated full year impact of
non-cash share-based compensation expense and employer portion of
payroll tax related to employee stock transactions of approximately $62
million, and amortization of acquired software and intangible assets of
approximately $51 million. Additionally, the non-GAAP tax rate of 24% is
estimated periodically as described below under “Non-GAAP Financial
Measures” and excludes approximately $27 million of estimated discrete
tax benefits that are included in the GAAP estimated annual effective
tax rate.

Conference Call

Tyler Technologies will hold a conference call on Thursday, May 2, at
10:00 a.m. EDT to discuss the company’s results. The company is offering
participants the opportunity to register in advance for the conference
through the following link: http://dpregister.com/10130477.
Registered participants will receive an email with a calendar reminder
and a dial-in number and PIN that will allow them immediate access to
the call on May 2.

Participants who do not wish to pre-register for the call may dial in
using 844-861-5506 (U.S. callers) or 412-317-6587 (international
callers) or 866-450-4696 (Canada callers) and ask for the “Tyler
Technologies” call. A replay will be available two hours after
completion of the call through May 30, 2019. To access the replay,
please dial 877-344-7529 (U.S. callers), 412-317-0088 (international
callers) and 855-669-9658 (Canada callers) and reference passcode
10130477.

The live webcast and archived replay can also be accessed at https://tylertech.irpass.com/presentations.

About Tyler Technologies, Inc.

Tyler Technologies (NYSE: TYL) is the largest and most established
provider of integrated software and technology services focused on the
public sector. Tyler’s end-to-end solutions empower local, state, and
federal government entities to operate more efficiently and connect more
transparently with their constituents and with each other. By connecting
data and processes across disparate systems, Tyler’s solutions are
transforming how clients gain actionable insights that solve problems in
their communities. Tyler has more than 21,000 successful installations
across 10,000 sites, with clients in all 50 states, Canada, the
Caribbean, Australia, and other international locations. A financially
strong company, Tyler has achieved double-digit revenue growth every
quarter since 2012. It was also named to Forbes’ “Best Midsize
Employers” list in 2018 and recognized twice on its “Most Innovative
Growth Companies” list. More information about Tyler Technologies,
headquartered in Plano, Texas, can be found at tylertech.com.

Non-GAAP Financial Measures

Tyler Technologies has provided in this press release financial measures
that have not been prepared in accordance with generally accepted
accounting principles (GAAP) and are therefore considered non-GAAP
financial measures. This information includes non-GAAP revenues,
non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income,
non-GAAP operating margin, non-GAAP net income, non-GAAP earnings per
diluted share, EBITDA, and adjusted EBITDA. We use these non-GAAP
financial measures internally in analyzing our financial results and
believe they are useful to investors, as a supplement to GAAP measures,
in evaluating Tyler’s ongoing operational performance because they
provide additional insight in comparing results from period to period.
Tyler believes the use of these non-GAAP financial measures provides an
additional tool for investors to use in evaluating ongoing operating
results and trends and in comparing our financial results with other
companies in our industry, many of which present similar non-GAAP
financial measures. Non-GAAP financial measures discussed above exclude
write-downs of acquisition-related deferred revenue and acquired leases,
share-based compensation expense, employer portion of payroll taxes on
employee stock transactions, expenses associated with amortization of
intangibles arising from business combinations, and acquisition-related
expenses.

Tyler currently uses a non-GAAP tax rate of 24%. This rate is based on
Tyler’s estimated annual GAAP income tax rate forecast, adjusted to
account for items excluded from GAAP income in calculating Tyler’s
non-GAAP income, as well as significant non-recurring tax adjustments.
The non-GAAP tax rate used in future periods will be reviewed
periodically to determine whether it remains appropriate in
consideration of factors including Tyler’s periodic effective tax rate
calculated in accordance with GAAP, changes resulting from tax
legislation, changes in the geographic mix of revenues and expenses, and
other factors deemed significant. Due to differences in tax treatment of
items excluded from non-GAAP earnings, as well as the methodology
applied to Tyler’s estimated annual tax rate as described above, the
estimated tax rate on non-GAAP income may differ from the GAAP tax rate
and from Tyler’s actual tax liabilities.

Non-GAAP financial measures should be considered in addition to, and not
as a substitute for, or superior to, financial information prepared in
accordance with GAAP. The non-GAAP measures used by Tyler Technologies
may be different from non-GAAP measures used by other companies.
Investors are encouraged to review the reconciliation of these non-GAAP
measures to their most directly comparable GAAP financial measures,
which has been provided in the financial statement tables included below
in this press release.

Forward-looking Statements

This document contains “forward-looking statements” within the meaning
of Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934 that are not historical in nature and
typically address future or anticipated events, trends, expectations or
beliefs with respect to our financial condition, results of operations
or business. Forward-looking statements often contain words such as
“believes,” “expects,” “anticipates,” “foresees,” “forecasts,”
“estimates,” “plans,” “intends,” “continues,” “may,” “will,” “should,”
“projects,” “might,” “could” or other similar words or phrases.
Similarly, statements that describe our business strategy, outlook,
objectives, plans, intentions or goals also are forward-looking
statements. We believe there is a reasonable basis for our
forward-looking statements, but they are inherently subject to risks and
uncertainties and actual results could differ materially from the
expectations and beliefs reflected in the forward-looking statements. We
presently consider the following to be among the important factors that
could cause actual results to differ materially from our expectations
and beliefs: (1) changes in the budgets or regulatory environments of
our clients, primarily local and state governments, that could
negatively impact information technology spending; (2) our ability to
protect client information from security breaches and provide
uninterrupted operations of data centers; (3) our ability to achieve
growth or operational synergies through the integration of acquired
businesses, while avoiding unanticipated costs and disruptions to
existing operations; (4) material portions of our business require the
Internet infrastructure to be adequately maintained; (5) our ability to
achieve our financial forecasts due to various factors, including
project delays by our clients, reductions in transaction size, fewer
transactions, delays in delivery of new products or releases or a
decline in our renewal rates for service agreements; (6) general
economic, political and market conditions; (7) technological and market
risks associated with the development of new products or services or of
new versions of existing or acquired products or services; (8)
competition in the industry in which we conduct business and the impact
of competition on pricing, client retention and pressure for new
products or services; (9) the ability to attract and retain qualified
personnel and dealing with the loss or retirement of key members of
management or other key personnel; and (10) costs of compliance and any
failure to comply with government and stock exchange regulations. A
detailed discussion of these factors and other risks that affect our
business are described in our filings with the Securities and Exchange
Commission, including the detailed “Risk Factors” contained in our most
recent annual report on Form 10-K. We expressly disclaim any obligation
to publicly update or revise our forward-looking statements.

 
TYLER TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Amounts in thousands, except per share data)
(Unaudited)
 
Three Months Ended March 31,
  2019     2018
Revenues:
Software licenses and royalties $ 21,793 $ 22,776
Subscriptions 67,275 49,028
Software services 48,443 45,939
Maintenance 100,152 93,897
Appraisal services 5,214 5,394
Hardware and other   4,189   4,140
Total revenues 247,066 221,174
 
Cost of revenues:
Software licenses and royalties 818 778
Acquired software 6,682 5,382
Software services, maintenance and subscriptions 117,160 106,085
Appraisal services 3,452 3,781
Hardware and other   2,906   2,343
Total cost of revenues 131,018 118,369
 
Gross profit 116,048 102,805
 
Selling, general and administrative expenses 57,766 47,604
Research and development expense 18,941 13,048
Amortization of customer and trade name intangibles   4,850   3,315
Operating income 34,491 38,838
Other income, net   586   599
Income before income taxes 35,077 39,437
Income tax provision   7,729   1,612
Net income $ 27,348 $ 37,825
 
 
Earnings per common share:
Basic $ 0.71 $ 1.00
Diluted $ 0.69 $ 0.95
 
Weighted average common shares outstanding:
Basic 38,308 38,002
Diluted 39,585 39,836
 
TYLER TECHNOLOGIES, INC.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(Amounts in thousands, except per share data)
(Unaudited)
 
Three Months Ended March 31,
  2019       2018  

Reconciliation of non-GAAP total revenues

GAAP total revenues $ 247,066 $ 221,174
Non-GAAP adjustments:
Add: Write-downs of acquisition-related deferred revenue 1,597 100
Add: Amortization of acquired leases   100     111  
Non-GAAP total revenues $ 248,763   $ 221,385  
 

Reconciliation of non-GAAP gross profit and
margin

GAAP gross profit $ 116,048 $ 102,805
Non-GAAP adjustments:
Add: Write-downs of acquisition-related deferred revenue 1,597 100
Add: Amortization of acquired leases 100 111
Add: Share-based compensation expense included in cost of revenues 3,798 2,776
Add: Amortization of acquired software   6,682     5,382  
Non-GAAP gross profit $ 128,225   $ 111,174  
GAAP gross margin   47.0 %   46.5 %
Non-GAAP gross margin   51.5 %   50.2 %
 

Reconciliation of non-GAAP operating income
and margin

GAAP operating income $ 34,491 $ 38,838
Non-GAAP adjustments:
Add: Write-downs of acquisition-related deferred revenue 1,597 100
Add: Amortization of acquired leases 100 111
Add: Share-based compensation expense 14,416 10,557
Add: Employer portion of payroll tax related to employee stock
transactions
123 320
Add: Acquisition related costs 695
Add: Amortization of acquired software 6,682 5,382
Add: Amortization of customer and trade name intangibles   4,850     3,315  
Non-GAAP adjustments subtotal   28,463     19,785  
Non-GAAP operating income $ 62,954   $ 58,623  
GAAP operating margin   14.0 %   17.6 %
Non-GAAP operating margin   25.3 %   26.5 %
 
TYLER TECHNOLOGIES, INC.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(Amounts in thousands, except per share data)
(Unaudited)
 
Three Months Ended March 31,
2019       2018  

Reconciliation of non-GAAP net income and
earnings per share

GAAP net income

$

27,348

$ 37,825
Non-GAAP adjustments:
Add: Total non-GAAP adjustments to operating income

 

28,463

19,785
Less: Tax impact related to non-GAAP adjustments

 

(7,521

)   (12,601 )
Non-GAAP net income

$

48,290

  $ 45,009  
GAAP earnings per diluted share

$

0.69

  $ 0.95  
Non-GAAP earnings per diluted share

$

1.22

  $ 1.13  
 

Detail of share-based compensation expense

Cost of software services, maintenance and subscriptions

$

3,798

$ 2,776
Selling, general and administrative expenses

 

10,618

    7,781  
Total share-based compensation expense

$

14,416

  $ 10,557  
 
 

Reconciliation of EBITDA and adjusted EBITDA

GAAP net income $ 27,348 $ 37,825
Amortization of customer and trade name intangibles 4,850 3,315
Depreciation and amortization included in
cost of revenues, SG&A and other expenses

12,426

10,797
Interest expense included in other income, net 464 189
Income tax provision   7,729     1,612  
EBITDA $

52,817

$ 53,738
Write-downs of acquisition-related deferred revenue 1,597 100
Share-based compensation expense 14,416 10,557
Acquisition related costs   695      
Adjusted EBITDA $

69,525

  $ 64,395  
   
TYLER TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands)
(Unaudited)
 
March 31, 2019 December 31, 2018
ASSETS
 
Current assets:
Cash and cash equivalents $ 39,437 $ 134,279
Accounts receivable, net 298,980 298,912
Current investments and other assets 63,857 80,970
Income tax receivable     4,697
Total current assets 402,274 518,858
 
Accounts receivable, long-term portion 22,821 16,020
Operating lease right-of-use assets 20,067
Property and equipment, net 164,617 155,177
 
Other assets:
Goodwill 834,572 753,718
Other intangibles, net 389,633 276,852
Non-current investments and other assets   75,318   70,338
 
Total assets $ 1,909,302 $ 1,790,963
 
 
LIABILITIES AND SHAREHOLDERS’ EQUITY
 
Current liabilities:
Accounts payable and accrued liabilities $ 69,835 $ 73,390
Current income tax payable 7,868
Operating lease liabilities 5,777
Deferred revenue   319,900   350,512
Total current liabilities 403,380 423,902
 
Revolving line of credit 85,000
Deferred revenue, long-term 442 424
Deferred income taxes 42,779 41,791
Operating lease liabilities, long-term 18,956
Shareholders’ equity   1,358,745   1,324,846
 
Total liabilities and shareholders’ equity $ 1,909,302 $ 1,790,963
 
TYLER TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in thousands)
(Unaudited)
 
Three Months Ended March 31,
  2019       2018  
Cash flows from operating activities:
Net income $ 27,348 $ 37,825
Adjustments to reconcile net income to cash
provided by operations:
Depreciation and amortization 17,308 14,112
Share-based compensation expense 14,416 10,557
Deferred income tax benefit (4,785 ) (2,658 )
Changes in operating assets and liabilities,
exclusive of effects of acquired companies   (30,330 )   (15,205 )
Net cash provided by operating activities   23,957     44,631  
 
Cash flows from investing activities:
Additions to property and equipment (12,320 ) (8,895 )
Purchase of marketable security investments (3,590 ) (43,962 )
Proceeds from marketable security investments 20,276 11,077
Investment in software (690 )
Cost of acquisitions, net of cash acquired (199,130 )
Decrease in other   564     743  
Net cash used by investing activities   (194,890 )   (41,037 )
 
Cash flows from financing activities:
Increase in net borrowings on revolving line of credit 85,000
Purchase of treasury shares (17,786 )
Proceeds from exercise of stock options 6,528 19,298
Contributions from employee stock purchase plan   2,349     1,798  
Net cash provided by financing activities   76,091     21,096  
 
Net (decrease) increase in cash and cash equivalents (94,842 ) 24,690
Cash and cash equivalents at beginning of period   134,279     185,926  
 
Cash and cash equivalents at end of period $ 39,437   $ 210,616  

Contacts

Brian K. Miller
Executive Vice President & CFO
Tyler
Technologies, Inc.
972-713-3720
[email protected]


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Rubicon Organics Reports Q1 2024 Financial Results

Published

on

Continue Reading

SCHWAZZE

Schwazze Announces First Quarter 2024 Financial Results

Published

on

schwazze-announces-first-quarter-2024-financial-results

Schwazze Management to Host Conference Call Today at 5:00 p.m. Eastern Time

DENVER, May 15, 2024 /PRNewswire/ — Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) (“Schwazze” or the “Company”), today announced financial and operational results for the first quarter ended March 31, 2024.

“We delivered another period of revenue growth in Q1 as we further refined our retail strategy while contending with the prolonged competitive challenges in Colorado and New Mexico,” said Forrest Hoffmaster, Interim CEO of Schwazze. “Throughout the quarter, we continued to sharpen our pricing and promotional efforts while enhancing the in-store experience, widening assortment, improving in-stock position, and advancing our loyalty program to attract and retain new customers. We also strengthened our wholesale business with quarter-over-quarter growth, while surpassing 30% total door penetration across both states.”

“The Colorado market remains highly competitive with more than 680 active recreational licenses, underscoring the importance of delivering an exceptional customer experience and fully integrated retail support program. Although retail pricing has recently stabilized, Colorado sales in Q1 were down 10% year-over-year due to lower volumes. Nonetheless, we significantly outpaced the market as our sales were up 9%, demonstrating the effectiveness of our operating playbook to compete in challenging environments. We expect to continue driving improvements in customer acquisition, retention, and loyalty as we further increase market share in the state.”

“In New Mexico, the proliferation of new licenses continued to outpace state cannabis sales as store count in Q1 increased 31% year-over-year while the market grew only 13%. In addition to pricing and promotional efforts, we’ve focused on driving traffic into our stores by expanding assortment with high quality flower and delivering an elevated customer experience. The New Mexico regulatory body has also increased its license enforcement efforts in recent months, contributing to more than 70 store closures and a 33% sequential decrease in net new store openings in the first quarter. We will continue to support the New Mexico Cannabis Control Division as it develops its regulatory framework.”

“Over the past four years we have rapidly scaled our footprint through 13 acquisitions, building a leading retail presence in both Colorado and New Mexico. We are beginning to see positive momentum from our pricing and promotional strategy and will remain focused on driving operating efficiencies while further optimizing our assets as we consolidate cultivation facilities and eliminate underperforming stores that do not meet our high-margin thresholds. We believe these initiatives, coupled with our operating playbook and strict cost controls, will enable us to return to stronger levels of profitability moving forward.”

First Quarter 2024 Financial Summary

$ in Thousands USD

Q1 2024

Q4 2023

Q1 2023

Total Revenue

$41,601

$43,325

$40,001

Gross Profit

$17,934

$7,034[1]

$21,849

Operating Expenses

$20,643

$23,276

$16,199

Income (Loss) from Operations

$(2,709)

$(16,242)

$5,650

Adjusted EBITDA[2]

$7,341

$10,953

$14,525

Operating Cash Flow

$(3,700)

$3,452

$(880)

Recent Highlights

  • Announced the grand opening of a medical and recreational dispensary in March under the Everest Apothecary banner in Las Cruces, New Mexico, increasing the Company’s retail footprint to 34 stores across the state.
  • Increased wholesale penetration in the first quarter to more than 30% of total doors in Colorado and New Mexico.
  • Lowell Herb Co. pre-roll sales increased more than 3x quarter-over-quarter in Colorado, where it continues to be the #1 pre-roll in the state.
  • Wana gummy sales up more than 2x quarter-over-quarter in New Mexico.

First Quarter 2024 Financial Results

Total revenue in the first quarter of 2024 increased 4% to $41.6 million compared to $40.0 million for the same quarter last year. The increase was primarily due to growth from new stores compared to the prior year period, partially offset by continued pricing pressure and the proliferation of new licenses in New Mexico.

Gross profit for the first quarter of 2024 was $17.9 million or 43.1% of total revenue, compared to $21.8 million or 54.6% of total revenue for the same quarter last year. The decrease in gross margin was primarily driven by the aforementioned pricing pressure in New Mexico, as well as higher medical sales mix in Colorado.

____________________________

1 Q4 2023 Gross Profit includes one-time, non-cash inventory adjustments of approximately $13.1 million comprised of $3.1 million of product consolidation, obsolescence, and shrinkage expenses, $4.3 million of net realizable value adjustments, and $5.8 million of fair value adjustments on acquired inventory in New Mexico in 2023. 
2  Adjusted EBITDA is a non-GAAP measure as defined by the SEC, and represents earnings before interest, taxes, depreciation, and amortization, adjusted for other income, non-cash share-based compensation, one-time transaction related expenses, or other non-operating costs. The Company uses Adjusted EBITDA as it believes it better explains the results of its core business. See “ADJUSTED EBITDA RECONCILIATION (NON-GAAP)” section herein for an explanation and reconciliations of non-GAAP measure used throughout this release.

Operating expenses for the first quarter of 2024 were $20.6 million compared to $16.2 million for the same quarter last year. The year-ago period benefitted from a payroll tax credit of $3.9M. The remaining increase was primarily driven by personnel expenses and four-wall SG&A costs associated with 21 additional stores in Colorado and New Mexico that are still ramping.

Loss from operations for the first quarter of 2024 was $2.7 million compared to income from operations of $5.6 million in the same quarter last year. Net loss was $16.1 million for the first quarter of 2024 compared to net income of $1.7 million for the same quarter last year.

Adjusted EBITDA for the first quarter of 2024 was $7.3 million compared to $14.5 million for the same quarter last year. The decrease in Adjusted EBITDA was primarily driven by lower gross margin and higher operating expenses associated with the 21 additional stores that are still ramping.

As of March 31, 2024, cash and cash equivalents were $13.2 million compared to $19.2 million on December 31, 2023. Total debt as of March 31, 2024, was $159.7 million compared to $156.8 million on December 31, 2023.

Conference Call

The Company will conduct a conference call today, May 15, 2024, at 5:00 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2024.

Schwazze management will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing [email protected].

Date: Wednesday, May 15, 2024
Time: 5:00 p.m. Eastern time
Toll-free dial-in: (888) 664-6383
International dial-in: (416) 764-8650
Conference ID: 84167910
Webcast: SHWZ Q1 2024 Earnings Call

The conference call will also be broadcast live and available for replay on the investor relations section of the Company’s website at https://ir.schwazze.com.

Toll-free replay number: (888) 390-0541
International replay number: (416) 764-8677
Replay ID: 167910

If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.

About Schwazze

Schwazze (OTCQX: SHWZ) (Cboe CA: SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to explore taking its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale.

Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector.

Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc. Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth. To learn more about Schwazze, visit https://schwazze.com/.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include financial outlooks; any projections of net sales, earnings, or other financial items; any statements of the strategies, plans and objectives of our management team for future operations; expectations in connection with the Company’s previously announced business plans; any statements regarding future economic conditions or performance; and statements regarding the intent, belief or current expectations of our management team. Such statements may be preceded by the words “may,” “will,” “could,” “would,” “should,” “expect,” “intends,” “plans,” “strategy,” “prospects,” “anticipate,” “believe,” “approximately,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other words of similar meaning in connection with a discussion of future events or future operating or financial performance, although the absence of these words does not necessarily mean that a statement is not forward-looking. We have based our forward-looking statements on management’s current expectations and assumptions about future events and trends affecting our business and industry. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. Therefore, forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) regulatory limitations on our products and services and the uncertainty in the application of federal, state, and local laws to our business, and any changes in such laws; (ii) our ability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (iii) our ability to identify, consummate, and integrate anticipated acquisitions; (iv) general industry and economic conditions; (v) our ability to access adequate capital upon terms and conditions that are acceptable to us; (vi) our ability to pay interest and principal on outstanding debt when due; (vii) volatility in credit and market conditions; (viii) the loss of one or more key executives or other key employees; and (ix) other risks and uncertainties related to the cannabis market and our business strategy. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.

Investor Relations Contact
Sean Mansouri, CFA or Aaron D’Souza
Elevate IR
(720) 330-2829
[email protected]

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
For the Periods Ended March 31, 2024 and December 31, 2023
Expressed in U.S. Dollars

 March 31,

December 31, 

2024

2023

 

ASSETS

 

Current Assets

Cash & Cash Equivalents

$

13,151,317

$

19,248,932

Accounts Receivable, net of Allowance for Doubtful Accounts

3,356,032

4,261,159

Inventory

26,382,184

25,787,793

Marketable Securities, net of Unrealized Loss of $347,516 and Loss of $1,816, respectively

108,583

456,099

Prepaid Expenses & Other Current Assets

3,502,310

3,914,064

Total Current Assets

46,500,426

53,668,047

Non-Current Assets

Fixed Assets, net Accumulated Depreciation of $10,061,700 and $8,741,782, respectively

31,326,000

31,113,630

Investments

2,000,000

2,000,000

Investments Held for Sale

202,111

Goodwill

67,492,705

67,499,199

Intangible Assets, net Accumulated Amortization of $36,483,160 and $32,706,765, respectively

162,391,482

166,167,877

Other Non-Current Assets

1,328,187

1,263,837

Operating Lease Right of Use Assets

34,575,832

34,233,142

Deferred Tax Assets, net

992,144

1,996,489

Total Non-Current Assets

300,106,350

304,476,285

Total Assets

$

346,606,776

$

358,144,332

 

LIABILITIES & STOCKHOLDERS’ EQUITY

 

Current Liabilities

Accounts Payable

$

9,443,233

$

13,341,561

Accrued Expenses

8,106,618

7,774,691

Derivative Liabilities

1,319,845

638,020

Lease Liabilities – Current

5,186,316

4,922,724

Current Portion of Long Term Debt

29,579,713

3,547,011

Income Taxes Payable

28,235,039

25,232,782

Total Current Liabilities

81,870,764

55,456,789

Non-Current Liabilities

Long Term Debt, net of Debt Discount & Issuance Costs

130,120,753

153,262,203

Lease Liabilities – Non-Current

30,735,072

30,133,452

Total Non-Current Liabilities

160,855,825

183,395,655

Total Liabilities

$

242,726,589

$

238,852,444

Stockholders’ Equity

Preferred Stock, $0.001 Par Value. 10,000,000 Shares Authorized; 82,185 Shares Issued and

82,185 Outstanding as of March 31, 2024 and 85,534 Shares Issued and 85,534 Outstanding as of

December 31, 2023.

82

86

Common Stock, $0.001 Par Value. 250,000,000 Shares Authorized; 79,168,539 Shares Issued

and 78,248,389 Shares Outstanding as of March 31, 2024 and 74,888,392 Shares Issued

and 73,968,242 Shares Outstanding as of December 31, 2023.

79,169

74,888

Additional Paid-In Capital

202,677,665

202,040,968

Accumulated Deficit

(96,843,602)

(80,790,927)

Common Stock Held in Treasury, at Cost, 920,150 Shares Held as of March 31, 2024 and

920,150 Shares Held as of December 31, 2023.

(2,033,127)

(2,033,127)

Total Stockholders’ Equity

103,880,187

119,291,888

Total Liabilities & Stockholders’ Equity

$

346,606,776

$

358,144,332

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME AND (LOSS)
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

(Unaudited)

(Unaudited)

Operating Revenues

Retail

$

37,633,252

$

35,820,111

Wholesale

3,898,320

4,058,925

Other

69,421

121,900

Total Revenue

41,600,993

40,000,936

Total Cost of Goods & Services

23,667,319

18,152,163

Gross Profit

17,933,674

21,848,773

Operating Expenses

Selling, General and Administrative Expenses

11,835,818

10,100,934

Professional Services

1,671,881

1,187,364

Salaries

6,880,988

4,695,971

Stock Based Compensation

253,916

214,544

Total Operating Expenses

20,642,603

16,198,813

Income from Operations

(2,708,929)

5,649,960

Other Income (Expense)

Interest Expense, net

(8,307,369)

(7,745,854)

Unrealized Gain (Loss) on Derivative Liabilities

(681,825)

8,501,685

Other Loss

10,500

Loss on Investment

(33,382)

Unrealized Gain on Investment

(347,516)

1,816

Total Other Income (Expense)

(9,359,592)

757,647

Pre-Tax Net Income (Loss)

(12,068,521)

6,407,607

Provision for Income Taxes

3,984,154

4,662,178

Net Income (Loss)

$

(16,052,675)

$

1,745,429

Less: Accumulated Preferred Stock Dividends for the Period

(2,155,259)

(2,029,394)

Net Income (Loss) Attributable to Common Stockholders

$

(18,207,934)

$

(283,965)

Earnings (Loss) per Share Attributable to Common Stockholders

Basic Earnings (Loss) per Share

$

(0.24)

$

(0.01)

Diluted Earnings (Loss) per Share

$

(0.24)

$

(0.06)

Weighted Average Number of Shares Outstanding – Basic

76,006,932

55,835,501

Weighted Average Number of Shares Outstanding – Diluted

76,006,932

101,608,278

Comprehensive Income (Loss)

$

(16,052,675)

$

1,745,429

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

(Unaudited)

(Unaudited)

Cash Flows from Operating Activities:

Net Income (Loss) for the Period

$

(16,052,675)

$

1,745,429

Adjustments to Reconcile Net Income (Loss) to Cash for Operating Activities

Depreciation & Amortization

5,096,314

6,151,395

Non-Cash Interest Expense

1,031,431

991,184

Non-Cash Lease Expense

2,871,226

2,251,459

Deferred Taxes

1,004,345

(637,225)

Loss on Investment

202,111

Change in Derivative Liabilities

681,825

(8,501,685)

Amortization of Debt Issuance Costs

421,512

421,513

Amortization of Debt Discount

2,303,246

1,999,933

(Gain) Loss on Investments, net

347,516

(1,816)

Stock Based Compensation

640,974

214,544

Changes in Operating Assets & Liabilities (net of Acquired Amounts):

Accounts Receivable

905,127

(118,181)

Inventory

(587,900)

(3,023,251)

Prepaid Expenses & Other Current Assets

411,754

(3,036,801)

Other Assets

(64,350)

360,674

Change in Operating Lease Liabilities

(2,348,703)

(1,531,765)

Accounts Payable & Other Liabilities

(3,566,401)

(3,464,671)

Income Taxes Payable

3,002,257

5,299,403

Net Cash Provided by (Used in) Operating Activities

(3,700,390)

(879,861)

Cash Flows from Investing Activities:

Collection of Notes Receivable

10,631

Purchase of Fixed Assets

(1,532,287)

(2,913,394)

Net Cash Provided by (Used in) Investing Activities

(1,532,287)

(2,902,763)

Cash Flows from Financing Activities:

Payment on Notes Payable

(864,938)

Net Cash Provided by (Used in) Financing Activities

(864,938)

Net (Decrease) in Cash & Cash Equivalents

(6,097,615)

(3,782,624)

Cash & Cash Equivalents at Beginning of Period

19,248,932

38,949,253

Cash & Cash Equivalents at End of Period

$

13,151,317

$

35,166,628

Supplemental Disclosure of Cash Flow Information:

Cash Paid for Interest

$

4,515,205

$

6,540,748

MEDICINE MAN TECHNOLOGIES, INC.
ADJUSTED EBITDA RECONCILIATION (NON-GAAP)
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

Net Income (Loss)

$

(16,052,675)

$

1,745,429

Interest Expense, net

8,307,369

7,745,854

Provision for Income Taxes

3,984,154

4,662,178

Other (Income) Expense, net of Interest Expense

1,052,223

(8,503,501)

Depreciation & Amortization

5,618,834

6,612,814

Earnings Before Interest, Taxes, Depreciation and

Amortization (EBITDA) (non-GAAP)

$

2,909,905

$

12,262,774

Non-Cash Stock Compensation

253,916

214,544

Deal Related Expenses

637,761

1,195,802

Capital Raise Related Expenses

20,760

35,068

Severance

484,561

118,436

Retention Program Expenses

807,500

280,632

Pre-Operating & Dark Carry Expenses

1,053,837

391,917

One-Time Legal Settlements

417,653

Other Non-Recurring Items

754,751

25,707

Adjusted EBITDA (non-GAAP)

$

7,340,644

$

14,524,880

Revenue

41,600,993

40,000,936

Adjusted EBITDA Percent

17.6 %

36.3 %

View original content:https://www.prnewswire.co.uk/news-releases/schwazze-announces-first-quarter-2024-financial-results-302146858.html

Continue Reading

Cannabis

Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032

Published

on

Continue Reading
Advertisement

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania